MedPlus announces that a drug license for one of its stores in Maharashtra has been suspended for twenty-five days. The suspension follows an order received on January 30, 2026, and relates to potential revenue loss of Rs 7.53 lacs. The company has made this information available on its website.
Drug License Suspension Details
MedPlus Health Services Limited has received a suspension order impacting the drug license of one of its stores located in Maharashtra. The license has been suspended for twenty-five days following an order issued by the Asst. Commissioner & Licensing authority, Food & Drug Administrations, Bhandara, Maharashtra.
Key Dates and Impact
The order was received on January 30, 2026. The suspension impacts a store situated at Santaji Ward Warthi Road, Bhanadara, Maharashtra. The potential revenue loss due to this suspension is estimated at Rs 7.53 lacs.
Regulatory Reference
The suspension is related to Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
Source: BSE
